Efficacy and Safety of MM-II for Treatment of Knee Pain in Subjects With Symptomatic Knee Osteoarthritis
Status:
Recruiting
Trial end date:
2021-11-01
Target enrollment:
Participant gender:
Summary
This is a phase IIb, randomized, double-blind, placebo-controlled study to determine the
efficacy and safety of MM-II in subjects with symptomatic knee OA as compared to matching
placebo.